Trial Profile
Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based Regimen.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Therapeutic Use
- 15 Nov 2009 New trial record